ctDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials

dc.contributor.authorMontagut Viladot, Clara
dc.contributor.authorVidal Barrull, Joana
dc.date.accessioned2019-11-08T08:37:32Z
dc.date.issued2019
dc.format.mimetypeapplication/pdf
dc.identifier.citationMontagut C, Vidal J. ctDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials. Ann Oncol. 2019 Sep 1;30(9):1410-1413. DOI 10.1093/annonc/mdz236
dc.identifier.doihttp://dx.doi.org/10.1093/annonc/mdz236
dc.identifier.issn0923-7534
dc.identifier.urihttp://hdl.handle.net/10230/42791
dc.language.isoeng
dc.publisherOxford University Press
dc.rights© Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Annals of oncology, following peer review. The version of record Montagut C, Vidal J. ctDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials. Ann Oncol. 2019 Sep 1;30(9):1410-1413, is available online at: https://academic.oup.com/annonc/article/30/9/1410/5550334. DOI 10.1093/annonc/mdz236
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.subject.otherPàncrees -- Càncer
dc.titlectDNA to detect minimal residual disease in pancreatic cancer: moving into clinical trials
dc.typeinfo:eu-repo/semantics/article
dc.type.versioninfo:eu-repo/semantics/acceptedVersion

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
montagut-aoo-ctdn.pdf
Size:
400.9 KB
Format:
Adobe Portable Document Format